Disease | membranous nephropathy |
Comorbidity | C0033687|proteinuria |
Sentences | 9 |
PubMedID- 26087670 | Rituximab, a monoclonal antibody that specifically targets cd20 on the surface of b-cells, is effective in achieving a complete remission of proteinuria in patients with idiopathic membranous nephropathy. |
PubMedID- 20101429 | Urine examination revealed 10.5 g/day proteinuria with membranous glomerulonephritis and his renal biopsy came up with it. |
PubMedID- 23814426 | [1] proteinuria is usually associated with membranous nephropathy, and it is rarely associated with minimal change disease or mesangioproliferative glomerulonephritis. |
PubMedID- PMC3991017 | However, it has not been reported in non-diabetic ckd and its role in residual proteinuria in patients with membranous nephropathy is unclear. |
PubMedID- 24174881 | Acthar® gel (acthar; questcor pharmaceuticals, inc., union city, ca, usa) has recently been shown to induce remission, defined as stabilization or improvement of renal function (by estimated glomerular filtration rate) and resolution of proteinuria, in patients with idiopathic membranous nephropathy.7 herein, we describe a case in which 13 months of treatment with acthar resulted in a sustained remission of membranous nephropathy in a patient with refractory disease. |
PubMedID- 24886340 | Remission of proteinuria in patients with idiopathic membranous nephropathy and nephrotic syndrome according to fe-igg level. |
PubMedID- 26558120 | He also had prior nephrotic range proteinuria documented with secondary membranous nephropathy of unspecified etiology. |
PubMedID- 22516683 | We report a case with abrupt onset of severe nephrotic-range proteinuria and hypoalbuminemia due to membranous glomerulonephritis that was associated with renal salt wasting and hypovolemia without edema. |
PubMedID- 23815417 | Background: idiopathic membranous nephropathy (imn) patients with persistent high-grade proteinuria are at the highest risk for developing end-stage renal failure. |
Page: 1